Eli Lilly Launches Competing Weight-Loss Drug Against Novo Nordisk's Wegovy

American pharmaceutical company Eli Lilly has launched a new weight-loss drug, intensifying competition with Novo Nordisk's popular Wegovy. Experts believe the Danish pharmaceutical company remains strong in the battle for market share.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

politikenDanish1d ago

Pillekrigen er nu i fuld gang

I denne uge lancerede amerikanske Eli Lilly en konkurrerende vægttabspille til Novo Nordisks Wegovy-pille. Ekspert vurderer, at det danske medicinalselskab står stærkt i kampen om amerikanernes gunst.

Read full article →

PERSPECTA

PERSPECTA

Eli Lilly Launches Competing Weight-Loss Drug Against Novo Nordisk's Wegovy

Sources

Pillekrigen er nu i fuld gang

Related Stories

Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory

Padel for Parkinson’s Cycling Event Held at University of Ghana for Awareness

Understanding and Managing Postpartum Sweating

Protecting Dogs from Viper Bites as Weather Warms

PERSPECTA